Here are the shots the government recommends currently for children and young people:
Hepatitis B: Three doses; one at birth, the second at 1-4 months, the third at 6-18 months.
Hepatitis A: Two doses; one between 12-23 months of age, the second at least 6 months after the first.
Inactivated poliovirus (IPV): Four doses; at 2 months, 4 months and 6-18 months, and a booster between 4-6 years.
Rotavirus: Three doses; the first at 6 weeks and 12 weeks of age. The series should be completed by the time the child is 32 weeks old.
Haemophilus Influenzae Type B (Hib): Three or four doses, depending on the brand used; doses are given at 2 months, 4 months, 6 months and 12-15 months.
Measles, mumps, rubella (MMR): Two doses; the first at 12-15 months; the second at least four weeks after the first, but usually at 4-6 years.
Pneumococcal conjugate (PCV): Four doses; at 2 months, 4 months, 6 months and 12-15 months.
Diphtheria, tetanus and acellular pertussis (DTaP): Five doses; at 2 months, 4 months, 6 months and 15-18 months of age. A booster is given at 4-6 years, when a child first enters school.
Tetanus diphtheria and acellular pertussis (Tdap): A version of DTaP for older children. One dose at age 11-12. A tetanus-diphtheria booster is recommended every 10 years through adulthood.
Varicella (chickenpox): One dose is recommended at 12-18 months. Last month, a government vaccine advisory committee voted to recommend a second dose at 4-6 years, but that has not yet been endorsed by the U.S. Centers for Disease Control and Prevention.
Influenza: Annual shots for children ages 6 months to 5 years.
Meningococcal, or bacterial meningitis (MCV4): This vaccine is considered longer-acting than an earlier meningococcal vaccine (MPSV4). MCV4 is recommended for adolescents at high school and college entry and children 11-12 — although the latter recommendation is currently suspended because of a vaccine shortage.
Human papillomavirus (HPV): The new vaccine, approved for marketing last month, combats cervical cancer. The vaccine advisory panel last month recommended the three-dose series be given to girls, starting at 11 or 12. Females 13-26 can also get the series, and it can be given to girls as young as 9.
The CDC is soon expected to endorse the committee recommendation for the HPV shot, although officials acknowledge the vaccine's cost may be a challenge for some families.